Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Savara, Inc. - Common Stock
(NQ:
SVRA
)
3.010
+0.080 (+2.73%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Savara, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
March 16, 2022
From
Savara Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
January 27, 2022
Gainers Avidity Biosciences (NASDAQ:RNA) s...
Via
Benzinga
Savara to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
January 04, 2022
From
Savara Inc.
Via
Business Wire
5 Penny Stocks Insiders Are Buying
December 20, 2021
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
December 14, 2021
Gainers Star Equity Hldgs (NASDAQ:STRR) s...
Via
Benzinga
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
December 02, 2021
From
Savara Inc.
Via
Business Wire
Savara to Participate in Two Upcoming Investor Healthcare Conferences
November 15, 2021
From
Savara Inc.
Via
Business Wire
Savara Reports Third Quarter 2021 Financial Results and Provides Business Update
November 12, 2021
From
Savara Inc.
Via
Business Wire
Savara to Present at the Jefferies London Healthcare Conference
November 10, 2021
From
Savara Inc.
Via
Business Wire
Savara to Present at the Inaugural Piper Sandler Lung Day
October 07, 2021
From
Savara Inc.
Via
Business Wire
3 Penny Stocks Insiders Are Buying
October 01, 2021
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...
Via
Benzinga
Savara to Participate in Two Upcoming Investor Healthcare Conferences
September 07, 2021
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
September 03, 2021
From
Savara Inc.
Via
Business Wire
5 Penny Stocks Insiders Are Buying
August 20, 2021
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...
Via
Benzinga
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
August 20, 2021
From
Savara Inc.
Via
Business Wire
5 Penny Stocks Insiders Are Buying
August 19, 2021
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 18, 2021
Gainers Protagenic Therapeutics (NASDAQ:PTIX...
Via
Benzinga
Savara Reports Second Quarter 2021 Financial Results and Provides Business Update
August 12, 2021
From
Savara Inc.
Via
Business Wire
Savara Announces First Patient Dosed in Pivotal Phase 3 Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Trial
June 30, 2021
From
Savara Inc.
Via
Business Wire
Savara to Present at the Jefferies Virtual Healthcare Conference
May 26, 2021
From
Savara Inc.
Via
Business Wire
Savara to Present at the Oppenheimer Rare & Orphan Disease Virtual Summit
May 17, 2021
From
Savara Inc.
Via
Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
May 14, 2021
From
Savara Inc.
Via
Business Wire
Savara Reports First Quarter 2021 Financial Results and Provides Business Update
May 13, 2021
From
Savara Inc.
Via
Business Wire
28 Stocks Moving in Wednesday's Pre-Market Session
May 05, 2021
Gainers Athenex, Inc. (NASDAQ: ATNX) shares rose 46.6% to $5.44 in pre-market trading after the company announced it acquired Kuur Therapeutics. iBio, Inc. (NYSE: IBIO) rose 29.5...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.